Overview

Pharmacokinetics and Hepatic Safety of EGCG

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
A trial to assess the pharmacokinetics and hepatic safety of EGCG in women with and without uterine fibroids.
Phase:
Phase 1
Details
Lead Sponsor:
Yale University
Collaborators:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Johns Hopkins University
University of Illinois at Chicago
Treatments:
Citric Acid
Clomiphene
Enclomiphene
Epigallocatechin gallate
Letrozole
Sodium Citrate
Zuclomiphene